BIMZELX 160 MG/ML AUTOINJECTOR

bimekizumab
$8046.4300per ML

Strength

160 mg/mL

Manufacturer

UCB, Inc.

NDC

50474078184

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

1/1/2026

Active Ingredients

BIMEKIZUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761151

On Market Since

10/17/2023

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+5.6%

Related Drugs

Same classification

No related drugs found.